Your browser doesn't support javascript.
loading
Author Correction: Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis.
Wang, Yinghong; Wiesnoski, Diana H; Helmink, Beth A; Gopalakrishnan, Vancheswaran; Choi, Kati; DuPont, Hebert L; Jiang, Zhi-Dong; Abu-Sbeih, Hamzah; Sanchez, Christopher A; Chang, Chia-Chi; Parra, Edwin R; Francisco-Cruz, Alejandro; Raju, Gottumukkala S; Stroehlein, John R; Campbell, Matthew T; Gao, Jianjun; Subudhi, Sumit K; Maru, Dipen M; Blando, Jorge M; Lazar, Alexander J; Allison, James P; Sharma, Padmanee; Tetzlaff, Michael T; Wargo, Jennifer A; Jenq, Robert R.
Afiliación
  • Wang Y; Department of Gastroenterology, Hepatology & Nutrition, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ywang59@mdanderson.org.
  • Wiesnoski DH; Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Helmink BA; Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Gopalakrishnan V; Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Choi K; Department of Internal Medicine, Baylor College of Medicine, Houston, TX, USA.
  • DuPont HL; Center for Infectious Diseases, School of Public Health, The University of Texas, Houston, TX, USA.
  • Jiang ZD; Kelsey Research Foundation, Houston, TX, USA.
  • Abu-Sbeih H; Center for Infectious Diseases, School of Public Health, The University of Texas, Houston, TX, USA.
  • Sanchez CA; Department of Gastroenterology, Hepatology & Nutrition, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Chang CC; Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Parra ER; Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Francisco-Cruz A; Department of Translational Molecular Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Raju GS; Department of Translational Molecular Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Stroehlein JR; Department of Gastroenterology, Hepatology & Nutrition, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Campbell MT; Department of Gastroenterology, Hepatology & Nutrition, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Gao J; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Subudhi SK; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Maru DM; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Blando JM; Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lazar AJ; Department of Immunology, Division of Basic Science Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Allison JP; Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Sharma P; Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tetzlaff MT; Department of Immunology, Division of Basic Science Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wargo JA; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Jenq RR; Department of Immunology, Division of Basic Science Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Nat Med ; 25(1): 188, 2019 Jan.
Article en En | MEDLINE | ID: mdl-30479380
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2019 Tipo del documento: Article